A1 Refereed original research article in a scientific journal
Association of Cerebral Oxygenation During Prehospital Anaesthesia and Functional Outcome: A Prospective, Observational Multi‐Centre Cohort Study of 1014 Patients
Authors: Saviluoto, Anssi; Raatiniemi, Lasse; Mäkelä, Simo; Toivonen, Tuukka; Setälä, Piritta; Kirves, Hetti; Tommila, Miretta; Toivonen, Pamela; Tukia, Simo; Nurmi, Jouni
Publisher: Wiley
Publication year: 2026
Journal: Acta Anaesthesiologica Scandinavica
Article number: e70161
Volume: 70
Issue: 1
ISSN: 0001-5172
eISSN: 1399-6576
DOI: https://doi.org/10.1111/aas.70161
Publication's open availability at the time of reporting: Open Access
Publication channel's open availability : Partially Open Access publication channel
Web address : https://doi.org/10.1111/aas.70161
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/505886124
Background
Many patients undergoing prehospital anaesthesia may be at risk of inadequate cerebral oxygenation due to underlying conditions or adverse events like hypotension or hypoxia. This study examined whether a decrease in regional cerebral oxygen saturation (rSO2) measured with near-infrared spectroscopy (NIRS) during prehospital anaesthesia associates with worse outcomes.
MethodsWe conducted a prospective, observational study including adult patients anaesthetised by six prehospital critical care teams. A relative cerebral desaturation event (rCDE) was defined as a ≥ 10% decrease in rSO2 for ≥ 5 min from baseline. An absolute cerebral desaturation event (aCDE) was defined as rSO2 < 60% during anaesthesia or lower than baseline if already < 60%. The primary outcome was favourable functional outcome (modified Rankin Scale ≤ 2) at 30 days and secondary outcomes included 30-day survival, 1-year functional outcome, and 1-year survival.
ResultsAmong 1014 patients, 199 experienced an rCDE, with 125 (63%) having supraphysiological baseline. rCDE was not associated with outcomes. Of 182 patients with aCDE, 30-day favourable outcomes were not significantly different (30% vs. 36%, p = 0.14, adjusted OR 0.92, 95% confidence interval 0.62–1.34). However, aCDE was associated with lower 30-day survival (46% vs. 58%, p = 0.006) and less favourable 1-year outcomes (31% vs. 41%, p = 0.043). Adjusted analyses showed no significant associations.
ConclusionAn rCDE was not associated with worse functional outcomes. While aCDEs were linked to unfavourable outcomes in unadjusted analyses, these associations were not significant after adjustment, highlighting the complexity of interpreting NIRS in heterogeneous populations. Condition-specific studies are needed to clarify its role.
Downloadable publication This is an electronic reprint of the original article. |
Funding information in the publication:
This work was supported by FinnHEMS and Helsinki University Hospital (state funding, TYH2021224 and TYH2022320). No funding was received from any device manufacturers or pharmaceutical companies.